Core Viewpoint - The company has signed a cooperation agreement with Beijing Jianguo Medical Technology Co., Ltd. to develop and promote cognitive digital therapy, aiming for standardization and accessibility in the field of cognitive disorders [1][2]. Group 1: Deepening Technical Exploration - The collaboration will enhance technical exploration and productization in mental health by integrating cutting-edge AI algorithms with clinical needs, leading to more precise and universal technology products [1]. Group 2: Establishing Industry Standards - The project will contribute to the establishment of national standards and market normalization, accumulating high-level evidence-based medical data and enhancing the authority of the company's solutions for nationwide promotion [2]. Group 3: Expanding Service Network - The initiative focuses on mental health welfare institutions and community settings, aiming to improve service capabilities for cognitive disorders, thereby increasing market penetration and creating significant social benefits [2]. Group 4: Strengthening Research Collaboration - The partnership with Beijing Jianguo Medical will solidify the company's collaboration network with national research institutions, with real-world data from long-term research cohorts serving as valuable assets for algorithm iteration and product optimization [2].

格隆汇1月4日丨脑动极光-B(06681.HK)宣布，公司间接全资附属公司浙江脑动极光医疗科技有限公司 ("浙江脑动极光")已与北京健国医疗科技有限公司("北京健国医疗")正式签署《认知数字疗法项目合作协 议》。双方将于2026年1月1日至2026年12月30日期间，围绕「认知功能评估训练精神卫生应用场景构建 与推广应用」课题开展深度合作，共同推动认知障碍数字疗法的标准化、规模化与可及化。 1.国标研究：联合研制认知障碍数字疗法核心技术指标体系、临床验证路径与应用规范，为国家标准立 项提供循证数据与草案文本。 本次合作是公司继参与国家科技重大专项及获批认知障碍数字疗法北京市重点实验室后，在认知障碍数 字疗法应用落地与生态构建方面的又一重要举措。 2.多中心试点：在杭州、南宁、武汉、牡丹江等地精神卫生福利机构及社区同步落地「脑动极光认知功 能评估与训练系统」，预计覆盖80%的目标机构，形成可复制的干预路径。 据悉，北京健国医疗依托北京健国科技集团在高端医疗科技领域的深厚产业基础和项目管理经验，专注 于康复医学技术的临床转化与推广。此次合作，正是双方将前沿数字诊疗算法与成熟产业化体系相结合 的实践，旨在共同推动认 ...

Group 1 - The stock of Brainstorm Cell Therapeutics Inc. (脑动极光-B) experienced a significant increase, rising over 8% to a peak of 6.82 HKD per share on December 29, with a current price of 6.73 HKD per share at 14:41 [1][4] Group 2 - On December 29, Brainstorm Cell Therapeutics announced a strategic cooperation agreement with LaHespa Health Management Holdings Group (莱贺思宝), focusing on product promotion and market expansion in Singapore [4] - This partnership marks the official launch of the company's market layout and business development in Southeast Asia, leveraging its digital therapy experience and technology accumulated in the Chinese market [4] - The collaboration is expected to enhance the company's brand influence and accelerate product implementation in local medical institutions, thereby shortening the market introduction cycle and expanding into diverse markets in digital health management [4]

Core Insights - Meditation has evolved into a widely used emotional regulation method, now entering a phase of quantifiable, assessable, prescribable, and immersive practices through the integration of brain science, psychology, AI emotional computing, and digital therapeutics [1][2] Group 1: AI Meditation System Launch - The AI Smart Meditation 1.0 system was officially launched by East China Normal University in collaboration with the affiliated mental health center, marking a shift from experiential to validated practices in meditation [1][3] - This system aims to digitize, mechanize, and scale meditation practices, exploring new paradigms in mental health services and promoting meditation into the "intelligent assistance era" [1][2] Group 2: System Features and Structure - The AI Smart Meditation system employs a core approach of "using AI to understand emotions, guiding practice with data, and driving behavior with feedback," creating a closed-loop intervention from perception to training to regulation [3][4] - It features a multi-faceted layout including a mobile app for guided training, AR meditation glasses for immersive experiences, and AI smart micro-rooms for immediate use in various settings, addressing diverse populations and needs [3][4] Group 3: Interdisciplinary Collaboration - The initiative represents a cross-disciplinary collaboration, aiming to transition meditation from a niche practice to a common capability, benefiting both healthy and ill populations beyond medical contexts [4][5] - Future developments will focus on creating clinical validation systems for youth emotional support, elderly sleep and cognitive regulation, and attention deficit groups, accelerating the transition of original research from the lab to society [4][5] Group 4: Application Potential - The AI Smart Meditation system introduces capabilities for measurement, feedback, and modeling, providing new scientific pathways for alleviating mental symptoms, emotional regulation, rehabilitation training, and attention improvement [5] - The integration of meditation with acoustic rhythms and the combination of AR meditation with music therapy are seen as future directions, enhancing the experience and adherence to wellness solutions [5]

Group 1 - The Beijing Municipal Government has launched the "Beijing Action Plan for Promoting the Transformation of Scientific and Technological Achievements (2025-2027)" to enhance medical innovation and research [1] - The Beijing Municipal Health Commission has initiated an excellent clinical research program for research-type wards, investing 200 million yuan to support 30 projects across 25 hospitals, focusing on 12 key diseases [1] - The Health Commission has developed three governance tools to analyze disease burden, compare domestic and international treatment levels, and identify unmet clinical needs, resulting in the identification of 100 major medical technology issues in the capital [1] Group 2 - In October 2022, Beijing introduced a pilot program for medical innovation and achievement transformation at hospitals, with 24 pilot projects covering innovative medical devices, drugs, and digital therapies [2] - The pilot projects include internationally pioneering solutions such as 3D-printed skull plates and new therapies for stroke and mental health [2] - The government has released a 2.0 version of the pilot program, emphasizing increased funding from hospitals, accelerated data value transformation, and improved decision-making processes to enhance the efficiency of technology transfer [2]

Core Insights - Digital therapy is emerging as a new medical intervention method, utilizing software programs and evidence-based medicine to provide health management, disease treatment, and rehabilitation support through technologies like AI, VR, and XR [3][4]. Policy Support and Industry Growth - Since 2022, Hainan has issued over 30 policies to support the development of the digital therapy industry, covering clinical research, product registration, promotion, payment exploration, and management [3]. - By July 2025, the number of digital therapy companies in Hainan is expected to reach 73, with nearly half located in the Hainan Ecological Software Park, which serves as a core engine for the industry's growth [3]. Product Development and Application - Digital therapy products developed by companies like Hainan Yuan Medical Technology Co., Ltd. include cognitive rehabilitation and psychological counseling, utilizing virtual reality to create engaging and effective treatment experiences [3][4]. - The gamified design of these products helps improve patient compliance, transforming the treatment experience from a passive obligation to an active participation [4]. Cost Efficiency - Traditional psychological counseling can be expensive, with hourly fees for specialists ranging from thousands of yuan, while digital therapy products are supported by the Hainan Provincial Health Commission and cost only around 20 yuan per session [4]. - Digital therapy can significantly reduce operational costs by eliminating the need for large physical spaces and additional staff, potentially saving 3 to 4 nursing personnel in a 50-bed ward [5]. Chronic Disease Management - Companies like Hainan Yiduo Cloud Health Industry Co., Ltd. are leveraging digital therapy for chronic disease management, having managed over 193,000 diabetes patients and nearly 500,000 hypertension patients across 12 cities in Hainan by August 2025 [5][6]. - The use of AI management software empowers village doctors to provide effective treatment for chronic diseases, improving the fasting blood sugar compliance rate by an average of 16.6% and the blood pressure compliance rate by 4.9% [6].

Core Insights - The company has successfully transformed from an automotive parts manufacturer to a leading player in the internet gaming industry, capitalizing on China's digital transformation strategy since 2014 [1][2] - In the first half of 2025, the company reported significant growth with revenue reaching 17.2 billion yuan, a year-on-year increase of 85.5%, and net profit soaring to 2.656 billion yuan, up 129.33% [1] Business Segments - The company operates three main business segments: internet gaming, automotive parts manufacturing, and artificial intelligence cloud data, while also exploring cutting-edge fields like AI and brain science [1][2] - The company has made substantial investments in "hard technology" and virtual-interactive fields, including the development of digital therapy products for conditions like ADHD and Alzheimer's [3] Technological Innovations - The company has engaged in the construction of a digital red culture experience space, integrating AR, VR, and AI technologies to enhance cultural education [3] - It has also invested in AI-driven quality inspection robots for various industries, addressing challenges like labor shortages and high energy consumption [4] Global Expansion - Century Games, a subsidiary, has expanded its gaming business globally, covering over 200 countries and regions, and has seen explosive growth through innovative game releases [5][6] - The game "Whiteout Survival" has achieved over 100 million downloads and topped global mobile game revenue charts, significantly contributing to the company's overseas income of 8.958 billion yuan in the first half of 2025 [6] Cultural Initiatives - The company integrates traditional culture into gaming, creating immersive experiences that promote cultural heritage through modern technology [7] - Collaborations with educational institutions have led to the development of games that serve as resources for traditional culture education [7] Social Responsibility - The company has established a sustainable development committee and has made over 30 million yuan in charitable donations, focusing on community service and social responsibility [8][9] - It has initiated various projects aimed at protecting minors and enhancing digital literacy, demonstrating a commitment to social trust and responsibility [9]

Core Insights - The stock of Brain Dynamics Aurora-B (06681) surged over 14%, reaching HKD 8.5 with a trading volume of HKD 311 million [1] Industry Developments - The Minister of Industry and Information Technology, Li Lecheng, emphasized the need to cultivate emerging industries and create new momentum during the 25th China International Industry Fair, focusing on technological innovation and the establishment of new pillar industries [1] - The National Medical Products Administration has approved the first medical device standard for brain-computer interface technology, which will be implemented on January 1, 2026, laying the foundation for the high-quality development of the brain-computer interface medical device industry [1] Company Highlights - Brain Dynamics Aurora's core product is a brain function information management platform software system, recognized as China's first regulatory-approved digital therapy product for cognitive impairment [2] - The company combines brain science with artificial intelligence, offering unique technological advantages such as virtual human technology and AI [2] - As the first company in China to develop a medical-grade digital therapy product for cognitive impairment, Brain Dynamics Aurora holds a first-mover advantage [2] - The core product is included in the provincial medical insurance reimbursement catalog across 30 provinces in China, enhancing product accessibility and market promotion [2] - The company has successfully established cognitive centers in over 120 hospitals in China, including several leading hospitals certified as "National Medical Centers" [2]

Group 1 - The core concept of the article revolves around the innovative digital therapy solutions provided by Yuan Yikang Health Technology Co., Ltd., which utilizes virtual reality to treat phobias and cognitive disorders [1][4] - Yuan Yikang's therapy involves immersive experiences where patients wear headsets to simulate high-altitude environments, gradually increasing their tolerance to heights [2][3] - The company integrates XR (Extended Reality) and AI technology to offer personalized treatment plans, enhancing diagnostic efficiency and resource management in healthcare [3][4] Group 2 - The digital therapy industry in Hainan has gained significant attention, with the province implementing over 30 supportive policies since 2022 to promote the sector [4] - By July 2025, Hainan is expected to host 73 digital therapy companies, with many being leading firms in their respective niches, particularly within the Hainan Eco-Software Park [4] - Yuan Yikang's cognitive function assessment and training software has received multiple certifications, including EU CE and UK MHRA, and is being marketed in Southeast Asia and Europe [4] Group 3 - The potential applications of digital therapy extend beyond phobias, exploring treatments for PTSD, addiction, autism, and cognitive recovery in elderly patients [5]

Core Viewpoint - The stock of Brainstorm Aurora-B (06681) experienced significant volatility, reaching a new high of 13.8 HKD before dropping over 14% in the afternoon, with a total trading range of 32% throughout the day [1] Group 1: Stock Performance - The stock had previously risen for four consecutive trading days, accumulating a total increase of 125% [1] - As of the latest report, the stock was down 14.84%, trading at 10.04 HKD, with a total transaction volume of 1.724 billion HKD [1] Group 2: Market Activity - Starting from September 8, Brainstorm Aurora was officially included in the Hong Kong Stock Connect list [1] - On September 9, the company attracted southbound capital for stock accumulation, with northbound investors holding 2.1124 million shares, representing 1.66% of total shares [1] Group 3: Company Overview - Brainstorm Aurora is the first domestic company to develop medical-grade digital therapy products targeting cognitive impairment [1] - Its core product is the first cognitive impairment digital therapy product in China to receive regulatory approval, with the first registration certificate obtained in September 2018 [1] Group 4: Financial Performance - In the first half of this year, the company reported revenue of 100 million RMB, reflecting a year-on-year increase of 92.82% [1] - The adjusted net loss for the same period was 88.022 million RMB, which is an increase of 11.64% year-on-year [1]